Preclinical Pharmacology of Metrifonate: A Promise for Alzheimer Therapy
Among the multiple transmitter deficits which have been described in Alzheimer’s Disease (AD), the degeneration of brain cholinergic cell bodies is the most sensitive, specific and severe, as indicated by the good correlation between the cholinergic pathology and dementia. Therefore, current drug development strategies in AD therapy focus on the enhancement of cholinergic neurotransmission. The most advanced class of compounds in this respect are cholinesterase (ChE) inhibitors which aim to restore the concentration of acetylcholine (ACh) in the synaptic cleft.
KeywordsDopamine Dementia Serotonin Coherence Acetylcholine
Unable to display preview. Download preview PDF.
- Becker RE, Moriearty P, Surbeck R, Unni L, Varney A and Vicari SK (1994): Second and third generation Cholinesterase inhibitors: clinical aspects. In: Alzheimer Disease: Therapeutic Strategies, Giacobini E and Becker R, eds. Boston: Birkhäuser, pp. 172–178.Google Scholar
- Hinz V, Grewig S and Schmidt BH (1996a): Metrifonate induces Cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem Res, in press.Google Scholar
- Hinz V, Grewig S and Schmidt BH (1996b): Metrifonate and dichlorvos: Effects of a single oral administration on Cholinesterase activity in rat brain and blood. Neurochem Res, in press.Google Scholar
- Kronforst MA, Moriearty PL, Ralphs M, Becker RE, Schmidt B, Thompson LT and Disterhoft JF (1995): Facilitation of learning in the aging rabbit after chronic metrifonate treatment. Soc Neurosci Abstr 21:196.Google Scholar
- Mori F, Lai CC, Fusi F and Giacobini E (1995b): Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neuro Report 6:633–636.Google Scholar
- Moriearty PL and Becker RE (1992): Inhibition of human brain and RBC acetylcholinesterase (AChE) by heptylphysostigmine (HPTL). Meth Find Clin Pharmacol 14:615–621.Google Scholar
- van der Staay FJ, Hinz VC and Schmidt BH (1996): Effects of metrifonate on escape and avoidance learning in young and aged rats. Behav Pharmacol 7:56–64.Google Scholar